loading...| Preferred Name |
Tumor lysis syndrome |
|
| Synonyms |
Tumor lysis syndrome adverse event |
|
| Definitions |
A disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells OR A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death. |
|
| ID |
http://purl.obolibrary.org/obo/CCTO_000802 |
|
| database_cross_reference |
NCIT:C3425 UMLS:C1963254 UMLS:C0041364 NCI:CTCAE:10045152 NCIT:C56638 |
|
| definition |
A disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells OR A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death. |
|
| has_exact_synonym |
Tumor lysis syndrome adverse event |
|
| has_obo_namespace |
cancer_care_treatment_outcome |
|
| id |
CCTO:000802 |
|
| label |
Tumor lysis syndrome |
|
| notation |
CCTO:000802 |
|
| prefLabel |
Tumor lysis syndrome |
|
| schema |
CCTO:000802(time_t t0) = EVENT_STATE(CCTO:000802, t0) |
|
| treeView | ||
| XSTOO_rule |
CCTO:000802 implies CCTO:001121 CCTO:000802 implies CCTO:000049 |
|
| subClassOf | ||
| is_assessed_by |